Artwork

Inhoud geleverd door Mark Davison. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Mark Davison of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

Dr. Kärt Tomberg - Making Better Protein Drugs

43:20
 
Delen
 

Manage episode 422767064 series 3556156
Inhoud geleverd door Mark Davison. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Mark Davison of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

The challenges of scientific entrepreneurship don’t end when you get funding.
In fact, a whole new set of challenges arise, from finding labs, to building your team and more.
In this episode I talk to Dr. Kärt Tomberg, CEO and co-founder of ExpressionEdits. She is now at that exact moment, where she has just secured £10 million of funding. So, who better to talk us through the pitching process and how to be successful at it.

Kärt discusses her journey into science from Estonia to Cambridge as well as her current work, where she is focusing on the importance of introns in gene expression to optimize protein production. She shares her experiences pitching to investors and why she actually enjoyed the process.

She also talks about how ExpressionEdits are leveraging artificial intelligence and machine learning to optimize the placement of introns in artificial genes. As well as the next steps for the company now funding has been secured.

“The vast majority of investors are not there to tell you how you should make your company” – Kärt Tomberg

You’ll hear about:

01:18 - Where does Kärt's love of science come from?

02:11- Growing up in Estonia

06:31 - What led Kärt to Cambridge?

09:51- Kärt on co-founding expression edits

17:45 - The mechanics behind Kärt's work

20:36 - How is AI used within Kärt's work?

25:16 - Therapeutics or tools

27:36 - Kärt's recent fundraising success

33:36 - How many pitches did Kärt have to make?

37:14 - Problems you face after investment

Follow Kärt:

LinkedIn - https://www.linkedin.com/in/tombergk/

ExpressionEdits on LinkedIn - https://www.linkedin.com/company/expressionedits/

ExpressionEdits - https://www.expressionedits.com/

Connect with Me:

LinkedIn: https://www.linkedin.com/in/markdavison100/

Grant Instruments: https://www.grantinstruments.com/

Grant Instruments on LinkedIn: https://www.linkedin.com/company/grant-instruments-cambridge-ltd/

  continue reading

Hoofdstukken

1. Dr. Kärt Tomberg - Making Better Protein Drugs (00:00:00)

2. Where does Kärt's love of science come from? (00:01:18)

3. Growing up in Estonia (00:02:11)

4. What led Kärt to Cambridge? (00:06:31)

5. Kärt on co-founding expression edits (00:09:51)

6. The mechanics behind Kärt's work (00:17:45)

7. How is AI used within Kärt's work? (00:20:36)

8. Therapeutics or tools (00:25:16)

9. Kärt's recent fundraising success (00:27:36)

10. How many pitches did Kärt have to make? (00:33:36)

11. Problems you face after investment (00:37:14)

12 afleveringen

Artwork
iconDelen
 
Manage episode 422767064 series 3556156
Inhoud geleverd door Mark Davison. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Mark Davison of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

The challenges of scientific entrepreneurship don’t end when you get funding.
In fact, a whole new set of challenges arise, from finding labs, to building your team and more.
In this episode I talk to Dr. Kärt Tomberg, CEO and co-founder of ExpressionEdits. She is now at that exact moment, where she has just secured £10 million of funding. So, who better to talk us through the pitching process and how to be successful at it.

Kärt discusses her journey into science from Estonia to Cambridge as well as her current work, where she is focusing on the importance of introns in gene expression to optimize protein production. She shares her experiences pitching to investors and why she actually enjoyed the process.

She also talks about how ExpressionEdits are leveraging artificial intelligence and machine learning to optimize the placement of introns in artificial genes. As well as the next steps for the company now funding has been secured.

“The vast majority of investors are not there to tell you how you should make your company” – Kärt Tomberg

You’ll hear about:

01:18 - Where does Kärt's love of science come from?

02:11- Growing up in Estonia

06:31 - What led Kärt to Cambridge?

09:51- Kärt on co-founding expression edits

17:45 - The mechanics behind Kärt's work

20:36 - How is AI used within Kärt's work?

25:16 - Therapeutics or tools

27:36 - Kärt's recent fundraising success

33:36 - How many pitches did Kärt have to make?

37:14 - Problems you face after investment

Follow Kärt:

LinkedIn - https://www.linkedin.com/in/tombergk/

ExpressionEdits on LinkedIn - https://www.linkedin.com/company/expressionedits/

ExpressionEdits - https://www.expressionedits.com/

Connect with Me:

LinkedIn: https://www.linkedin.com/in/markdavison100/

Grant Instruments: https://www.grantinstruments.com/

Grant Instruments on LinkedIn: https://www.linkedin.com/company/grant-instruments-cambridge-ltd/

  continue reading

Hoofdstukken

1. Dr. Kärt Tomberg - Making Better Protein Drugs (00:00:00)

2. Where does Kärt's love of science come from? (00:01:18)

3. Growing up in Estonia (00:02:11)

4. What led Kärt to Cambridge? (00:06:31)

5. Kärt on co-founding expression edits (00:09:51)

6. The mechanics behind Kärt's work (00:17:45)

7. How is AI used within Kärt's work? (00:20:36)

8. Therapeutics or tools (00:25:16)

9. Kärt's recent fundraising success (00:27:36)

10. How many pitches did Kärt have to make? (00:33:36)

11. Problems you face after investment (00:37:14)

12 afleveringen

Alle afleveringen

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding